1. Dextran reduces embolic signals after carotid endarterectomy
- Author
-
Andrew K. Roberts, Jacinda L. Stork, Anna Peeters, M C Hoare, Heather Cameron, Christopher R Levi, Anthony T. W. Chan, Anne L. Abbott, Brian R. Chambers, John Royle, G. Fell, and Geoffrey A. Donnan
- Subjects
Male ,Ultrasonography, Doppler, Transcranial ,medicine.medical_treatment ,Carotid endarterectomy ,Placebo ,chemistry.chemical_compound ,Postoperative Complications ,medicine.artery ,medicine ,Humans ,Carotid Stenosis ,Embolization ,Stroke ,Aged ,Endarterectomy ,Endarterectomy, Carotid ,business.industry ,Anticoagulants ,Dextrans ,Middle Aged ,medicine.disease ,Transcranial Doppler ,Dextran ,Intracranial Embolism ,Neurology ,chemistry ,Anesthesia ,Injections, Intravenous ,Middle cerebral artery ,Female ,Neurology (clinical) ,business - Abstract
One hundred fifty patients undergoing carotid endarterectomy were randomly assigned to receive intravenous 10% dextran 40 or placebo. Transcranial Doppler monitoring of the ipsilateral middle cerebral artery 0 to 1 hour postoperatively detected embolic signals in 57% of placebo and 42% of dextran patients, with overall embolic signal counts 46% less for dextran (p = 0.052). Two to 3 hours postoperatively, embolic signals were present in 45% of placebo and 27% of dextran patients, with embolic signal counts 64% less for dextran (p = 0.040). We conclude that dextran reduces embolic signals within 3 hours of CEA.
- Published
- 2001
- Full Text
- View/download PDF